Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10919129 | Radiotherapy and Oncology | 2013 | 7 Pages |
Abstract
Our data suggest that sorafenib may be used to overcome the radioresistance of HNSCC through the inhibition of DSB repair.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Simon Laban, Leonhard Steinmeister, Lisa GleiÃner, Tobias J. Grob, Reidar Grénman, Cordula Petersen, Andreas Gal, Rainald Knecht, Ekkehard Dikomey, Malte Kriegs,